NYX-330

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNYX-330
Drug Alias NameNYX-330
ClassificationSmall molecules
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCardio Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCardio Therapeutics Pty Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A